Caprihans India Limited (BOM:509486)

India · Delayed Price · Currency is INR

72.43

-2.06 (-2.77%)

At close: Jul 31, 2026

-49.10% (1Y)

Market Cap	1.28B -38.7%
Revenue (ttm)	7.02B -5.1%
Net Income	-470.00M
EPS	-32.08
Shares Out	17.62M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	597
Open	74.49
Previous Close	74.49
Day's Range	71.30 - 74.49
52-Week Range	50.30 - 144.60
Beta	0.67
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 10, 2026

About Caprihans India

Caprihans India Limited engages in the pharmaceutical packaging business in India and internationally. The company also manufactures and sells rigid and flexible polyvinyl chloride (PVC) films, polyvinylidene chloride (PVDC) coated films, plastic extruded products, alu alu foils, and other allied products. In addition, it provides thermoforming blister films under the Duplex, Triplex, Ultra, Ultra Tx, Armour, Aclar, Excel, Exxtra, Optra, BAPP, Zymax, Zymax Tx, and Zymax PDP names; coldforming blister foils under the Venus, Venus PR, Venus SBC, ... [Read more]

Industry Miscellaneous Plastics Products

Founded 1946

Employees 540

Stock Exchange Bombay Stock Exchange

Ticker Symbol 509486

Full Company Profile

Financial Performance

In fiscal year 2026, Caprihans India's revenue was 7.02 billion, a decrease of -5.09% compared to the previous year's 7.40 billion. Losses were -470.00 million, -24.41% less than in 2025.

Financial Statements